Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm

J Am Coll Cardiol. 2016 Aug 16;68(7):739-41. doi: 10.1016/j.jacc.2016.06.014.
No abstract available

Keywords: STEMI; diabetes mellitus; myocardial infarction; myocardial revascularization.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal
  • Diabetes Mellitus
  • Humans
  • Immunoglobulin Fab Fragments*
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • ST Elevation Myocardial Infarction*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Abciximab